FUJIFILM Pharmaceuticals U.S.A., Inc.


Fujifilm is concentrating on R&D for new drugs that focus on such diseases as the oncology domain, where effective treatments are yet to be found. By taking advantage of our core technologies, such as analysis, synthesis and nanotechnologies, we are pursuing new approaches to develop novel drugs that contribute to unmet medical needs.

Listed below are pipelines currently under U.S. clinical studies sponsored by FUJIFILM Pharmaceuticals U.S.A., Inc.

* A couple of early stage compounds are also under development